 
 
 
 
 
 
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.  
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. 
 
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana., India.  Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833  
Email: info@aurobindo.com     Website: www.aurobindo.com  
 
November 14, 2025 
 
To 
Listing Department, 
NATIONAL STOCK EXCHANGE OF INDIA LIMITED 
Exchange Plaza, Bandra Kurla Complex, Bandra (E), 
MUMBAI -400 051 
 
Company Code No. AUROPHARMA 
To 
The Corporate Relations Department 
BSE LIMITED 
Phiroz Jeejeebhoy Towers, 25 th floor, Dalal Street, 
MUMBAI -400 001 
 
Company Code No. 524804 
 
Dear Sir / Madam, 
 
Sub: Completion of US FDA Inspection at Unit II of Eugia Pharma Specialities Ltd., Bhiwadi, a wholly owned 
subsidiary of the Company – Reg., 
 
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this 
is to inform you that:  
 
The United States Food and Drug Administration (US FDA) inspected Unit -II, a Formulation manufacturing 
facility, of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of the Company, situated at Bhiwadi, 
Alwar, Rajasthan, from November 03rd to November 14th, 2025. 
 
The inspection concluded with 9 observations. The observations are procedural in nature and will be 
responded to within the stipulated time.  
 
The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities 
across the globe . We will keep the stock exchanges informed if there is any further information relating to 
the above in the future.  
 
Please take the above information on record. 
 
Yours faithfully, 
For AUROBINDO PHARMA LIMITED 
 
 
B. Adi Reddy  
Company Secretary  
 
Encl.: Annexure  
 
 
 
 
 
 
 
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.  
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. 
 
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana., India.  Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833  
Email: info@aurobindo.com     Website: www.aurobindo.com  
 
Annexure 
 
Sr. No. Particulars Details 
1 Name of the authority US Food and Drug Administration (US FDA), USA 
2 
Nature and details of the action(s) 
taken, initiated or order(s) passed by 
the Authority 
US FDA inspected Unit-II, a Formulation manufacturing 
facility, of Eugia Pharma Specialities Ltd., a wholly owned 
subsidiary of the Company, situated at Bhiwadi, Alwar, 
Rajasthan, from November 3 to November 14, 2025. 
3 
Date of receipt of direction or order, 
including any ad-interim or interim 
orders, or any other communication 
from the authority 
November 14, 2025 
4 
Details of the violation(s)/ 
contravention(s) committed or 
alleged to be committed 
The inspection concluded with 9 observations. The 
observations are procedural in nature and will be 
responded to within the stipulated time. 
5 
Impact on financial, operation, or 
other activities of the listed entity, 
quantifiable in monetary terms to 
the extent possible 
This development will not have any impact on the existing 
operations of the Unit. 
 
